Roger E. Susi sold $452k of IRMD
CEO, PRESIDENT, CHAIRMAN at IRADIMED CORP. 5,000 shares at an average of $90.36, traded Nov 24, 2025, filed Nov 24, 2025.
Score components
- +25RoleCEO
- +17Trade size$452k at market
- 0Share of holdings soldSold 0.2% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001613801-25-000033, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -556 | $89.67 | $50k | 2,311,944 | Nov 24, 2025 |
| Nov 24, 2025 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -3,558 | $90.31 | $321k | 2,308,386 | Nov 24, 2025 |
| Nov 24, 2025 | SOpen-market sale Common Stockindirect: By Phillip Susi 2008 Dynasty Trust10b5-1 | -886 | $91.01 | $81k | 2,307,500 | Nov 24, 2025 |
Related signals
Other insiders at IRADIMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $123k 1,419 shares | -7% | |
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $100k 1,000 shares | -5% | |
| 23Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $488k 5,000 shares | -0% | |
| 38Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $484k 5,000 shares | -0% | |
| 38Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $484k 5,000 shares | -0% | |
| 67Notable | IRADIMED CORP | John Glenn CHIEF FINANCIAL OFFICER | $1.5M 15,000 shares | -67% | |
| 44Moderate | IRADIMED CORP | James B Hawkins director | $290k 3,000 shares | -9% | |
| 38Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $477k 5,000 shares | -0% | |
| 37Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $464k 5,000 shares | -0% | |
| 43Moderate | IRADIMED CORP | James B Hawkins director | $265k 3,000 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.